Low-level viremia-induced liver fibrosis and hepatocellular carcinoma in chronic hepatitis B
10.3760/cma.j.cn501113-20211124-00577
- VernacularTitle:慢性乙型肝炎低病毒血症致肝纤维化与肝细胞癌
- Author:
Zhengzhao LU
1
;
Yameng SUN
;
Hong YOU
Author Information
1. 首都医科大学附属北京友谊医院肝病中心 100050
- Keywords:
Chronic hepatitis B;
Hepatocellular carcinoma;
Fibrosis;
Low-level viremia;
Antiviral treatment
- From:
Chinese Journal of Hepatology
2021;29(12):1144-1146
- CountryChina
- Language:Chinese
-
Abstract:
Low-level viremia after antiviral therapy has gradually attracted attention due to its relation to liver fibrosis progression, hepatocellular carcinoma occurrence and long-term survival rate reduction in patients with chronic hepatitis B. In addition, it should be used as a risk factor for intervention during antiviral therapy in order to achieve complete virological response and improve the long-term prognosis of patients.
